Samir Gharib

Samir Gharib

Director Financiero/CFO en SPRUCE BIOSCIENCES, INC. .

Fortuna: 423 644 $ al 31/05/2026

43 años
Health Technology
Consumer Services
Commercial Services

Perfil

Samir M.
Gharib
is currently the Director at Cancer CAREpoint since 2017.
Mr. Gharib is also the President & Chief Financial Officer at Spruce Biosciences, Inc. since 2022.
Formerly, Mr. Gharib was Finance Director & Controller at Talon Therapeutics, Inc. from 2012 to 2013.
Mr. Gharib was Managing Director at Benchmark Financial Partners LLC from 2017 to 2018.
Mr. Gharib was Vice President-Finance & Administration at Revance Therapeutics, Inc. from 2013 to 2017.
Mr. Gharib was Chief Financial Officer at Stemedica Cell Technologies, Inc. from 2018 to 2019.
Education includes an undergraduate degree conferred in 2005 and an MBA from Haas School of Business.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
24/03/2026 8.263 ( 0,77 % ) 423 644 $ 31/05/2026

Cargos activos de Samir Gharib

EmpresasCargoInicio
SPRUCE BIOSCIENCES, INC. Director Financiero/CFO 01/05/2020
Director/Miembro de la Junta 01/11/2017

Antiguos cargos conocidos de Samir Gharib.

EmpresasCargoFin
Director Financiero/CFO 01/09/2019
Benchmark Financial Partners LLC
Corporate Officer/Principal 01/10/2018
REVANCE THERAPEUTICS, INC. Director Financiero/CFO 01/09/2017
Director Financiero/CFO 01/09/2013
Ver el detalle de la experiencia de Samir Gharib.

Formación de Samir Gharib.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

81

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas7

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Benchmark Financial Partners LLC